Safety processes and regulations apply to custom-made medicines, which differ from traditional pharmacies. Now, however, ...

Pharmaceutical corporations Eli Lilly, Novo Nordisk, and Sanofi have been challenged by Doctors Without Borders to take ...

In 1970, with a degree from the medical school of the University of Copenhagen (UCPH), Professor Jens Juul Holst embarked on ...

noted that Novo Nordisk’s weight loss drug Ozempic sells for $969 ... In the case of Ozempic and similar GLP-1 drugs, the ...

A woman who started taking a popular weight loss medication through a clinical trial had to look for alternatives when her ...

Neither company accepts insurance for their GLP-1 products, but the versions they sell are vastly cheaper than those sold by ...

Shares of BioAge Labs (BIOA), a biopharmaceutical company focused on obesity drugs, opened 25% above its initial public ...

Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

Semaglutide – a key ingredient in Ozempic and Wegovy – was associated with a lower risk of opioid overdose in patients with Type 2 diabetes and opioid use disorder, research shows.

Shares of BioAge Labs opened 25% above their initial public offering price on Thursday in a strong debut for the weight-loss drug developer against the backdrop of surging investor enthusiasm.

The arrival of GLP-1 analog drugs (such as Wegovy) marked a huge shift in the weight-loss drug market. These drugs have been ...